Tenax Therapeutics (TENX) Change in Cash: 2010-2017
Historic Change in Cash for Tenax Therapeutics (TENX) over the last 7 years, with Dec 2017 value amounting to -$159,073.
- Tenax Therapeutics' Change in Cash fell 101.72% to -$159,073 in Q4 2017 from the same period last year, while for Dec 2017 it was -$8.4 million, marking a year-over-year decrease of 232.45%. This contributed to the annual value of $85.1 million for FY2024, which is 1009.27% up from last year.
- According to the latest figures from Q4 2017, Tenax Therapeutics' Change in Cash is -$159,073, which was up 66.14% from -$469,803 recorded in Q3 2017.
- In the past 5 years, Tenax Therapeutics' Change in Cash registered a high of $9.3 million during Q4 2016, and its lowest value of -$36.4 million during Q3 2014.
- Over the past 3 years, Tenax Therapeutics' median Change in Cash value was -$1.3 million (recorded in 2016), while the average stood at -$1.2 million.
- Within the past 5 years, the most significant YoY rise in Tenax Therapeutics' Change in Cash was 664.91% (2014), while the steepest drop was 1,205.42% (2014).
- Quarterly analysis of 5 years shows Tenax Therapeutics' Change in Cash stood at $2.5 million in 2013, then slumped by 398.93% to -$7.6 million in 2014, then spiked by 88.24% to -$4.3 million in 2015, then reached $9.3 million in 2016, then crashed by 101.72% to -$159,073 in 2017.
- Its Change in Cash stands at -$159,073 for Q4 2017, versus -$469,803 for Q3 2017 and -$4.8 million for Q2 2017.